Cathepsin B and middle cerebral artery occlusion in the rat

Journal of Neurosurgery

Volumn 87, Issue 5, 1997, Pages 716-723

  Seyfried, Donald ^a   Han, Yuxia ^b   Zheng, Zhang ^b   Day, Nancy ^b   Moin, Kamiar ^b   Rempel, Sandra ^b   Sloane, Bonnie ^b   Chopp, Michael ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

Cathepsin B; Cysteine protease; Focal cerebral ischemia; Middle cerebral artery occlusion; Protease inhibitor; Rat; Stefin A

Indexed keywords

CATHEPSIN B; CYSTEINE PROTEINASE INHIBITOR; STEFIN A;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; ENZYME ACTIVATION; ENZYME ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION;

EID: 0030668593     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.5.0716     Document Type: Article

References (42)

1. Akopov SE, Sercombe R, Seylaz J: Leukocyte-induced acute endothelial dysfunction in middle cerebral artery in rabbits. Response to aggregating platelets. Stroke 25:2246-2252, 1994
2. Banati RB, Rothe G, Valet G, et al: Detection of lysosomal cysteine proteinases in microglia flow cytometric measurement and histochemical localization of cathepsin B and L. Glia 7: 183-191, 1993
3. Bartus RT, Hayward NJ, Elliott PJ, et al: Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration. Stroke 25: 2265-2270, 1994
4. Bode W, Musil D, Zucic D, et al: The refined x-ray crystal structures of human and rat liver cathepsin B, in Katunuma N, Suzuki K, Travis J, et al (eds): Biological Functions of Proteases and Inhibitors. Tokyo: Japan Scientific Societies Press, 1994, pp 23-34
5. Bolli R, Cannon RO, Speir E, et al: Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin pepstatin and chymostatin administered in vivo. J Am Coll Cardiol 2:671-680, 1983
6. Brorson JR, Marcuccilli CJ, Miller RJ: Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26: 1259-1266, 1995
7. Cataldo AM, Paskevich PA, Kominami E, et al: Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci USA 88:10998-11002, 1991
8. Chen H, Chopp M, Schultz L, et al: Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat. J Neurol Sci 118:109-116, 1993
9. Chopp M, Zhang RL, Chen H, et al: Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25:869-876, 1994
10. Chue CH, Yukioka N, Yamada E, et al: The possible role of lysosomal enzymes in the pathogenesis of hypertensive cerebral lesions in spontaneously hypertensive rats. Acta Neuropathol 85:383-389, 1993
11. Clark WM, Calcagno FA, Gabler WL, et al: Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment. Stroke 25:1411-1416, 1994
12. Decker RS, Poole AR, Crie JS, et al: Lysosomal alterations in hypoxic and reoxygenated hearts. II. Immunohistochemical and biochemical changes in cathepsin D. Am J Pathol 98:445-452, 1980
13. Decker RS, Poole AR, Wildenthal K: Distribution of lysosomal cathepsin D in normal, ischemic, and starved rabbit cardiac myocytes. Circ Res 46:485-494, 1980
14. Decker RS, Poole R, Griffin EE, et al: Altered distribution of lysosomal cathepsin D in ischemic myocardium. J Clin Invest 59:911-921, 1977
15. Fong D, Kartasova T, Sloane BF, et al: Bacterial expression in human cysteine proteinase inhibitor stefin A. FEBS Lett 257: 55-58, 1989
16. Garcia JH, Yoshida Y, Chen H, et al: Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol 142:623-635, 1993
17. Jochum M, Machleidt W, Fritz H: Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches, in Katunuma N, Suzuki K, Travis J, et al (eds): Biological Functions of Proteases and Inhibitors. Tokyo: Japan Scientific Societies Press, 1994, pp 161-180
18. Kominami E, Tsukahara T, Bando Y, et al: Distribution of cathepsins B and H in rat tissues and peripheral blood cells. J Biochem 98:87-93, 1985
19. Lah TT, Babnik J, Schiffmann E, et al: Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease. J Periodontol 64 (Suppl 5):485-491, 1993
20. Lee KS, Frank S, Vanderklish P, et al: Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 88:7233-7237, 1991
21. Li XK, Matin AFM, Suzuki H, et al: Effect of protease inhibitor on ischemia/reperfusion injury of the rat liver. Transplantation 56:1331-1336, 1993
22. Matsuo Y, Onodera H, Shiga Y, et al: Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 25:1469-1475, 1994
23. Mikkelsen T, Yan PS, Ho KL, et al: Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg 83:285-290, 1990
24. Moin K, Day NA, Sameni M, et al: Human tumour cathepsin B. Comparison with normal liver cathepsin B. Biochem J 285: 427-434, 1992
25. Nakamura Y, Takeda M, Suzuki H, et al: Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neurosci Lett 130:195-198, 1991
26. Nakanishi H, Tsukuba T, Kondou T, et al: Transient forebrain ischemia induces increased expression and specific localization of cathepsins E and D in rat hippocampus and neostriatum. Exp Neurol 121:215-223, 1993
27. Ogata N, Yanekawa Y, Taki W, et al: Degradation of neurotilament protein in cerebral ischemia. J Neurosurg 70:103-107, 1989
28. Ohshita T, Nikawa T, Towatari T, et al: Effects of selective inhibition of cathepsin B and general inhibition of cysteine proteinases on lysosomal proteolysis in rat liver in vivo and in vitro. Eur J Biochem 209:223-231, 1992
29. Okuda M, Lefer AM: Lysosomal hypothesis in evolution of myocardial infarction. Subcellular fractionation and electron microscopic cytochemical study. Jap Heart J 20:643-656, 1979
30. Paxinos G, Watson C: The Rat Brain in Stereotactic Coordinates. San Diego: Academic Press, 1986
31. Rami A, Knieglstein J: Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res 609:67-70, 1993
32. Rempel SA, Rosenblum ML, Mikkelsen T, et al: Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 54:6027-6031, 1994
33. Roberts-Lewis JM, Savage MJ, Marcy VR, et al: Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 14: 3934-3944, 1994
34. Rozhin J, Gomez AP, Ziegler GH, et al: Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res 50:6278-6284, 1990
35. Sasai Y, Nakamura N, Kobayashi Y, et al: Studies on intracardiac acid hydrolases in the ischemic myocardial necrosis. Jap Circ J 46:1337-1344, 1982
36. Siman R, Gall C, Perlmutter LS, et al: Distribution ot calpain I, an enzyme associated with degenerative activity, in rat brain. Brain Res 347:399-403, 1985
37. Siman R, Noszek JC, Kegerise C: Calpain I activation is specitically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9:1579-1590, 1988
38. Takio K, Towatari T, Katunuma N, et al: Homology of amino acid sequences of rat liver cathepsins B and H with that of papain. Proc Natl Acad Sci USA 80:3666-3670, 1983
39. Zalewska T, Kasai Y, Kawashima S: Calcium-dependent proteolytic activity in hypoxic rat brain. Biomed Biochem Acta 48:S166-S169, 1989
40. Zea Longa Z, Weinstein PR, Carlson S, et al: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989
41. Zhang RL, Chopp M, Chen H, et al: Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J Neurol Sci 125:3-10, 1994
42. Zhang RL, Chopp M, Jiang N, et al: Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26:1438-1443, 1995